Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Healthways Inc raises low end of prior FY 2014 revenue outlook to a range in line with analysts' estimates; gives FY 2014EPS outlook below analysts' estimates


Thursday, 13 Feb 2014 04:00pm EST 

Healthways Inc:Says it updated its FY 2014 financial guidance.Expects FY 2014 revenues in a range of $730-$760 mln, an increase from the preliminary range of $725-$760 mln that was provided in Oct. 2013.Expects FY 2014 net income per diluted share in a range of breakeven to $0.15, which includes $0.11 of non-cash interest expense.Expects FY 2014 adjusted net income per diluted share, which excludes non-cash interest expense, is in a range of $0.11 to $0.26.FY 2014 revenue of $736 mln, EPS of $0.31 - Thomson Reuters I/B/E/S. 

Company Quote

19.11
-0.24 -1.24%
19 Dec 2014